share_log
Moomoo 24/7 ·  Apr 18 16:08
Lumos Pharma Announces Abstracts Reviewing Data From Its Phase 2 OraGrowth210 And OraGrowth212 Trials Will Be Presented At Upcoming Medical Meetings
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment